Request Your Free White Paper Now:

"Unraveling the Complexities in Nasal Vaccine Development, Manufacturing, and Device Selection"

In a recent webinar, Catalent experts shared their insights on developing intranasal products and scaling them for commercial supply.

This executive summary will share insights into intranasal vaccine formulation development and discuss the current state of the art in intranasal vaccine production from development to commercial scale. In addition, a detailed discussion on the challenges and opportunities of intranasal approaches will be presented including the importance of device selection in determining product performance.

In this executive summary, readers will learn about:

• Key factors that determine the success of an intranasal vaccine formulation
• Key manufacturing capabilities of intranasal vaccines
• The impact of key device characteristics on the delivery of liquid and powder based intranasal vaccines

Offered Free by: Catalent Pharma Solutions
See All Resources from: Catalent Pharma Solutions